Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement

• Main Authors: Bruce A. Warden (Author), Johannes Steiner (Author), Albert Camacho (Author), Khoa Nguyen (Author), Jonathan Q Purnell (Author), P. Barton Duell (Author), Courtney Craigan (Author), Diane Osborn (Author), Sergio Fazio (Author)
• Format: Book
• Published: Elsevier, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Heart failure with reduced ejection fraction (HFrEF) is a debilitating disease that is associated with substantial morbidity, mortality, and societal costs. The past three decades have brought about significant advancements in the pharmacologic management of HFrEF, and a corresponding reduction in m...